Showing results 1 to 20 of 20
Issue Date | Title | Author(s) |
---|---|---|
2019-10 | A carrier-free multiplexed gene editing system applicable for suspension cells | Ju, Anna; Lee, Sung Won; Lee, Young Eun; Han, Ki-Cheol; Kim, Jin-Chul; Shin, Sang Chul; Park, Hyun Jung; Kim, Eunice EunKyeong; Hong, Seokmann; Jang, Mihue |
2023-10 | A CRISPR activation screen identifies MUC-21 as critical for resistance to NK and T cell-mediated cytotoxicity | Lee, Dong-hee; Ahn, Hyejin; Sim hye in; Choi, Eunji; Choi, Seung hyun; JO, YUNJU; Yun, Bohwan; Song, Hyun Kyu; Oh, Soo Jin; Denda-Nagai, Kaori; Park, Chan-Sik; Irimura, Tatsuro; Park, Yoon; Jin, Hyung-seung |
2015-02-10 | A polymeric conjugate foreignizing tumor cells for targeted immunotherapy in vivo | Lee, Young-Ho; Yoon, Hong Yeol; Shin, Jung Min; Saravanakumar, G.; Noh, Kyung Hee; Song, Kwon-Ho; Jeon, Ju-Hong; Kim, Dong-Wan; Lee, Kyung-Mi; Kim, Kwangmeyung; Kwon, Ick Chan; Park, Jae Hyung; Kim, Tae Woo |
2023-08 | Advances in mRNA therapeutics for cancer immunotherapy: From modification to delivery | Han, Geonhee; Noh, Dahye; Lee, Hokyung; Lee, Sangmin; Kim, Sehoon; Yoon, Hong Yeol; Lee, Soo Hyeon |
2022-11 | Advantage of extracellular vesicles in hindering the CD47 signal for cancer immunotherapy | KIM YOON KYOUNG; Yeonsun Hong; Bae Young Rang; Goo, ji young; Seong A KIM; YunjungChoi; Gi-hoon Nam; Minsu Kwon; Seung Gyu Yun; LEE GYEJUN; Jeong, Cherlhyun; Kim, In San |
2024-05 | An electro-ferroptotic nanoammunition enables image-guided, spatiotemporally controlled cancer ferroptosis induction via irreversible electroporation | Han, Jun-Hyeok; Seo, Hee Seung; Lee, Jiyoung; Chen, Zheng; Wang, Qiyue; Lee, Yun Young; Lee, Na Kyeong; Kang, Jeon Min; Kim, Song Hee; Hong, Hwichan; Park, Jung-Hoon; Piao, Yuanzhe; Li, Fangyuan; Na, Kun; Park, Chun Gwon; Park, Wooram; Ling, Daishun |
2024-03 | Cancer cell-specific and pro-apoptotic SMAC peptide-doxorubicin conjugated prodrug encapsulated aposomes for synergistic cancer immunotherapy | Kim, Jinseong; Shim, Man Kyu; Moon, Yujeong; Kim, Jeongrae; Cho, Hanhee; Yun, Wan Su; Shim, Nayeon; Seong, Joon-Kyung; Lee, Yonghyun; Lim, Dong-Kwon; Kim, Kwangmeyung |
2014-02-10 | Complex adaptive therapeutic strategy (CATS) for cancer | Cho, Yong Woo; Kim, Sang Yoon; Kwon, Ick Chan; Kim, In-San |
2024-09 | Deep Learning-Based Automated Analysis of NK Cell Cytotoxicity in Single Cancer Cell Arrays | Moon, Dowon; Kim, Seong-Eun; Wang, Chuangqi; Lee, Kwonmoo; Doh, Junsang |
2022-01 | Development of small-molecule sting activators for cancer immunotherapy | JUNG HEERA; Jo, S.; Jeon, M.J.; LEE HYE LIM; CHU, YEON JEONG; Lee Jee Hee; Kim, E.; Song, G.Y.; Jung, C.; Kim, H.; Lee, Sang hee |
2022-11 | Discovery of 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one and 3,4-dihydropyrido[2,3-d]pyrimidin-2(1H)-one derivatives as novel ENPP1 inhibitors | Cheong Jaeeun; Yunseong Jang; Jeong Hee Jin; Kim, Sung Joon; Park, Kichul; OH DO HEE; Yu, Ahran; Park, Chan Sun; Han, Seojung |
2017-03 | Exosome-SIRP alpha, a CD47 blockade increases cancer cell phagocytosis | Koh, Eunee; Lee, Eun Jung; Nam, Gi-Hoon; Hong, Yeonsun; Cho, Eunji; Yang, Yoosoo; Kim, In-San |
2017-12 | Harnessing designed nanoparticles: Current strategies and future perspectives in cancer immunotherapy | Jo, Sung Duk; Nam, Gi-Hoon; Kwak, Gijung; Yang, Yoosoo; Kwon, Ick Chan |
2021-01-31 | Hitting the complexity of the TIGIT-CD96-CD112R-CD226 axis for next-generation cancer immunotherapy | Jin, Hyung-Seung; Park, Yoon |
2023-07 | Immune checkpoint-targeted drug conjugates: A promising tool for remodeling tumor immune microenvironment | Choi, Jiwoong; Jang, Hochung; Choi, Jiwon; Choi, Yeonho; Yang, Yoosoo; Shim, Man Kyu; Kim, Sun Hwa |
2019-11 | Intrinsic cancer vaccination | Yang, Yoosoo; Nam, Gi-Hoon; Kim, Gi Beom; Kim, Yoon Kyoung; Kim, In-San |
2022-11 | Liposome-mediated PD-L1 multivalent binding promotes the lysosomal degradation of PD-L1 for T cell-mediated antitumor immunity | YANG SUAH; 심만규; 송수경; Hanhee Cho; choi, ji woong; Seong Ik Jeon; Kim W.J.; Um W.; Park J.H.; 윤홍열; Kim, Kwang meyung |
2024-07 | M1-polarized macrophage-derived cellular nanovesicle-coated lipid nanoparticles for enhanced cancer treatment through hybridization of gene therapy and cancer immunotherapy | Shin, Ha Eun; Han, Jun-Hyeok; Shin, Seungyong; Bae, Ga-Hyun; Son, Boram; Kim, Tae-Hyung; Park, Hee Ho; Park, Chun Gwon; Park, Wooram |
2024-03 | Photo-induced crosslinked and anti-PD-L1 peptide incorporated liposomes to promote PD-L1 multivalent binding for effective immune checkpoint blockade therapy | Lee Young-Joo; Song, Sukyung; Yang, Suah; Kim, Jinseong; MOON, YU JEONG; Shim, Nayeon; Yoon, Hong Yeol; Kim, Se hoon; Shim, Man Kyu; Kim, Kwangmeyung |
2022-04 | Tumor-activated carrier-free prodrug nanoparticles for targeted cancer Immunotherapy: Preclinical evidence for safe and effective drug delivery | Shim, Man Kyu; Yang, Suah; Sun, In-Cheol; Kim, Kwangmeyung |